Premium
GENE POLYMORPHISMS AS PREDICTORS OF TREATMENT EFFICACY AND TOXICITY IN PATIENTS WITH INDOLENT NON‐HODGKIN LYMPHOMAS RECEIVING BENDAMUSTINE AND RITUXIMAB
Author(s) -
Cencini E.,
Sicuranza A.,
Fabbri A.,
Raspadori D.,
Bocchia M.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2439_128
Subject(s) - single nucleotide polymorphism , medicine , genotyping , rituximab , oncology , immunology , lymphoma , cancer research , genotype , biology , gene , genetics